-
Case Studies
![]()
Arctic Expedition Cruises – Case Study
Arctic Expedition Cruises Report Overview Expedition cruising refers to a way of exploring far-off and remote places where it is difficult to go by traditional modes of travel. In the last few years, there has been an increase in expedition cruises owing to the expansion of transportation networks and the establishment of sea routes. Expedition cruises in the Arctic allow tourists to witness and experience wildlife and nature adventures. It includes ecological and sustainable tourism, but there is also a...
-
Thematic Analysis
![]()
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Product Insights
![]()
Optic Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Optic Neuropathy - Drugs In Development, 2023’, provides an overview of the Optic Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Optic Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
![]()
Delayed Graft Function (DGF) – Drugs In Development, 2023
Global Markets Direct’s, ‘Delayed Graft Function (DGF) - Drugs In Development, 2023’, provides an overview of the Delayed Graft Function (DGF) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Delayed Graft Function (DGF), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
![]()
Allergic Conjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Conjunctivitis - Drugs In Development, 2023’, provides an overview of the Allergic Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
![]()
Conjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Conjunctivitis - Drugs In Development, 2023’, provides an overview of the Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
![]()
Open-Angle Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Open-Angle Glaucoma - Drugs In Development, 2023’, provides an overview of the Open-Angle Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
![]()
Hearing Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Hearing Disorders - Drugs In Development, 2023’, provides an overview of the Hearing Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hearing Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
![]()
Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Glaucoma - Drugs In Development, 2023’, provides an overview of the Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Company Profile
![]()
Valio Ltd – Company Profile
Valio Ltd (Valio) produces, develops and sells dairy products. It also collects, process, markets and distributes milk-based and its related food products. The company’s product portfolio includes butter, cheese, yogurt, milk powders, milk drinks and snacks. Valio also provides quarks, whey powders, milk powders, lactose free milk powders, fruit preparations and baby food and infant formulas. The company also develops functional foods and unique milk processing technologies. It markets its products under several brands including Valio Profeel, Valio ValSa, Valio...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.